Matches in SemOpenAlex for { <https://semopenalex.org/work/W58304170> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W58304170 endingPage "110" @default.
- W58304170 startingPage "99" @default.
- W58304170 abstract "Objectives : The current treatment regimens for patients with nephrotic syndrome due to membranous nephropathy(MN) are based on steroids or immunosuppressive therapy with the aim of reducing proteinuria and improving outcome. Although these treatments attenuate the deterioration of renal function in MN patients, it has been suggested that all are burdened by significant toxicity. Therefore, more specific and less toxic therapies are needed. This study was to evaluate the effects of Coptidis Rhizoma Extract(CRE) on the MN induced by cBSA in mice. Methods : Mice were divided into 4 groups. One group named for 'Normal' was injected with a saline solution not to be immunized. The rest groups were treated as follows; After mice were immunized with 0.2 mg of cBSA and Freund's complete adjuvant one time every two weeks for 6 weeks, they received intra-peritoneal injection of 10 mg/kg of cBSA daily for 4 weeks. Also, they were divided into 3 groups. The first named for 'Control' was not given CRE. The second for 'CRE-250' was given oral administration of 250 mg/kg of CRE daily for 4 weeks. The third for 'CRE-500' was given 500 mg/kg of CRE. All of mice were sacrificed 4 weeks after the first immunization. We measured a body weight and 24hrs proteinuria as well as serological analysis. The morphologic changes of renal glomeruli were also observed with a light microscope and an electron microscope. Results : The levels of 24 hrs proteinuria, triglyceride, IgG, IL-6 were significantly decreased in both CRE groups. And the level of IgM was significantly decreased in CRE-250 group. In histological findings of kidney tissue, thickening of GBM and deposition of electron-density were consideraly decreased in both CRE groups. Conclusions : The present study suggests that CRE is highly effective when treating mice with MN induced by cBSA. More clinical data and studies are to be done for efficient application." @default.
- W58304170 created "2016-06-24" @default.
- W58304170 creator A5041822916 @default.
- W58304170 creator A5043783580 @default.
- W58304170 creator A5067248153 @default.
- W58304170 date "2009-01-01" @default.
- W58304170 modified "2023-09-23" @default.
- W58304170 title "Effects of the Coptidis Rhizoma Extract on the Membranous Nephropathy induced by Cationic Bovine Serum Albumin in Mice" @default.
- W58304170 hasPublicationYear "2009" @default.
- W58304170 type Work @default.
- W58304170 sameAs 58304170 @default.
- W58304170 citedByCount "0" @default.
- W58304170 crossrefType "journal-article" @default.
- W58304170 hasAuthorship W58304170A5041822916 @default.
- W58304170 hasAuthorship W58304170A5043783580 @default.
- W58304170 hasAuthorship W58304170A5067248153 @default.
- W58304170 hasConcept C126322002 @default.
- W58304170 hasConcept C134018914 @default.
- W58304170 hasConcept C203014093 @default.
- W58304170 hasConcept C2775946357 @default.
- W58304170 hasConcept C2776125364 @default.
- W58304170 hasConcept C2777863537 @default.
- W58304170 hasConcept C2778930706 @default.
- W58304170 hasConcept C2779561371 @default.
- W58304170 hasConcept C2779922275 @default.
- W58304170 hasConcept C2780091579 @default.
- W58304170 hasConcept C2781184683 @default.
- W58304170 hasConcept C555293320 @default.
- W58304170 hasConcept C71924100 @default.
- W58304170 hasConcept C86807702 @default.
- W58304170 hasConcept C98274493 @default.
- W58304170 hasConceptScore W58304170C126322002 @default.
- W58304170 hasConceptScore W58304170C134018914 @default.
- W58304170 hasConceptScore W58304170C203014093 @default.
- W58304170 hasConceptScore W58304170C2775946357 @default.
- W58304170 hasConceptScore W58304170C2776125364 @default.
- W58304170 hasConceptScore W58304170C2777863537 @default.
- W58304170 hasConceptScore W58304170C2778930706 @default.
- W58304170 hasConceptScore W58304170C2779561371 @default.
- W58304170 hasConceptScore W58304170C2779922275 @default.
- W58304170 hasConceptScore W58304170C2780091579 @default.
- W58304170 hasConceptScore W58304170C2781184683 @default.
- W58304170 hasConceptScore W58304170C555293320 @default.
- W58304170 hasConceptScore W58304170C71924100 @default.
- W58304170 hasConceptScore W58304170C86807702 @default.
- W58304170 hasConceptScore W58304170C98274493 @default.
- W58304170 hasIssue "1" @default.
- W58304170 hasLocation W583041701 @default.
- W58304170 hasOpenAccess W58304170 @default.
- W58304170 hasPrimaryLocation W583041701 @default.
- W58304170 hasRelatedWork W2073289209 @default.
- W58304170 hasRelatedWork W2097047744 @default.
- W58304170 hasRelatedWork W2352694150 @default.
- W58304170 hasRelatedWork W2353986722 @default.
- W58304170 hasRelatedWork W2358621850 @default.
- W58304170 hasRelatedWork W2359989166 @default.
- W58304170 hasRelatedWork W2362212322 @default.
- W58304170 hasRelatedWork W2364429483 @default.
- W58304170 hasRelatedWork W2366235808 @default.
- W58304170 hasRelatedWork W2366727763 @default.
- W58304170 hasRelatedWork W2372194877 @default.
- W58304170 hasRelatedWork W2376411421 @default.
- W58304170 hasRelatedWork W2378958547 @default.
- W58304170 hasRelatedWork W2379332049 @default.
- W58304170 hasRelatedWork W2379438217 @default.
- W58304170 hasRelatedWork W2387567852 @default.
- W58304170 hasRelatedWork W2390751326 @default.
- W58304170 hasRelatedWork W2390820918 @default.
- W58304170 hasRelatedWork W2404074060 @default.
- W58304170 hasRelatedWork W913569204 @default.
- W58304170 hasVolume "24" @default.
- W58304170 isParatext "false" @default.
- W58304170 isRetracted "false" @default.
- W58304170 magId "58304170" @default.
- W58304170 workType "article" @default.